# Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease

> **NCT06012097** · PHASE4 · RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 70 (estimated)

## Conditions studied

- De Quervain Disease

## Interventions

- **DRUG:** Diclofenac gel
- **DRUG:** Aromatherapy gel

## Key facts

- **NCT ID:** NCT06012097
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-04
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06012097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06012097, "Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06012097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*